WFDC10B
gene geneOn this page
Also known as WAP12
Summary
WFDC10B (WAP four-disulfide core domain 10B, HGNC:20479) is a protein-coding gene on chromosome 20q13.12, encoding Protein WFDC10B (Q8IUB3).
This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the telomeric cluster. Two alternatively spliced transcript variants have been found for this gene, and they encode distinct isoforms.
Source: NCBI Gene 280664 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 26 total
- MANE Select transcript:
NM_172006
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20479 |
| Approved symbol | WFDC10B |
| Name | WAP four-disulfide core domain 10B |
| Location | 20q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | WAP12 |
| Ensembl gene | ENSG00000182931 |
| Ensembl biotype | protein_coding |
| Entrez | 280664 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000330523, ENST00000335769, ENST00000937249
RefSeq mRNA: 2 — MANE Select: NM_172006
NM_172006, NM_172131
CCDS: CCDS13365, CCDS13366
Canonical transcript exons
ENST00000330523 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001309290 | 45685902 | 45686056 |
| ENSE00003621896 | 45704918 | 45705019 |
| ENSE00003629256 | 45704497 | 45704561 |
| ENSE00003930807 | 45684651 | 45684960 |
Expression profiles
Bgee: expression breadth ubiquitous, 123 present calls, max score 87.81.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0464 / max 20.0146, expressed in 11 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187471 | 0.0464 | 11 |
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.81 | gold quality |
| cauda epididymis | UBERON:0004360 | 70.67 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 70.02 | gold quality |
| right testis | UBERON:0004534 | 68.61 | gold quality |
| corpus epididymis | UBERON:0004359 | 67.41 | gold quality |
| left testis | UBERON:0004533 | 66.91 | gold quality |
| skin of leg | UBERON:0001511 | 64.98 | gold quality |
| testis | UBERON:0000473 | 64.52 | gold quality |
| skin of abdomen | UBERON:0001416 | 61.92 | gold quality |
| zone of skin | UBERON:0000014 | 60.59 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 60.31 | gold quality |
| upper lobe of lung | UBERON:0008948 | 58.37 | gold quality |
| caput epididymis | UBERON:0004358 | 57.35 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 55.15 | gold quality |
| lower esophagus | UBERON:0013473 | 54.94 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 54.84 | gold quality |
| mucosa of stomach | UBERON:0001199 | 54.35 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 53.89 | gold quality |
| right lung | UBERON:0002167 | 53.71 | gold quality |
| fundus of stomach | UBERON:0001160 | 53.69 | gold quality |
| urinary bladder | UBERON:0001255 | 53.47 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 52.88 | gold quality |
| transverse colon | UBERON:0001157 | 51.96 | gold quality |
| apex of heart | UBERON:0002098 | 51.83 | gold quality |
| left coronary artery | UBERON:0001626 | 51.65 | gold quality |
| coronary artery | UBERON:0001621 | 50.60 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 50.04 | gold quality |
| rectum | UBERON:0001052 | 49.64 | gold quality |
| tibial artery | UBERON:0007610 | 49.34 | gold quality |
| popliteal artery | UBERON:0002250 | 49.29 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.30 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
13 targeting WFDC10B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-29B-1-5P | 98.86 | 68.35 | 1364 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-211-3P | 98.14 | 66.77 | 1052 |
| HSA-MIR-219B-5P | 97.91 | 65.80 | 531 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-105-3P | 89.64 | 64.48 | 52 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG5639 | FBGN0039527 |
| caenorhabditis_elegans | WBGENE00015620 |
Paralogs (9): PI3 (ENSG00000124102), SLPI (ENSG00000124107), WFDC3 (ENSG00000124116), WFDC13 (ENSG00000168634), WFDC12 (ENSG00000168703), WFDC5 (ENSG00000175121), WFDC11 (ENSG00000180083), WFDC9 (ENSG00000180205), WFDC10A (ENSG00000180305)
Protein
Protein identifiers
Protein WFDC10B — Q8IUB3 (reviewed: Q8IUB3)
All UniProt accessions (1): Q8IUB3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Tissue specificity. Ubiquitously expressed.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IUB3-1 | 1, WAP12a | yes |
| Q8IUB3-2 | 2, WAP12b |
RefSeq proteins (2): NP_742003, NP_742143 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008197 | WAP_dom | Domain |
UniProt features (5 total): signal peptide 1, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUB3-F1 | 86.02 | 0.59 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 30 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_HUMORAL_IMMUNE_RESPONSE, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOBP_RESPONSE_TO_BACTERIUM, GOMF_ENZYME_REGULATOR_ACTIVITY, GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE, GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY, LHX9_TARGET_GENES, MIR4441, MIR4270
GO Biological Process (2): antibacterial humoral response (GO:0019731), innate immune response (GO:0045087)
GO Molecular Function (3): serine-type endopeptidase inhibitor activity (GO:0004867), protein binding (GO:0005515), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| antimicrobial humoral response | 1 |
| defense response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| binding | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
212 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WFDC10B | WFDC3 | Q8IUB2 | 657 |
| WFDC10B | SPINT4 | Q6UDR6 | 642 |
| WFDC10B | WFDC13 | Q8IUB5 | 583 |
| WFDC10B | ZSWIM1 | Q9BR11 | 580 |
| WFDC10B | SPATA25 | Q9BR10 | 575 |
| WFDC10B | SNX21 | Q969T3 | 526 |
| WFDC10B | C6orf163 | Q5TEZ5 | 518 |
| WFDC10B | CFAP107 | Q8N1D5 | 507 |
| WFDC10B | WFDC11 | Q8NEX6 | 480 |
| WFDC10B | NEURL2 | Q9BR09 | 480 |
| WFDC10B | WFDC6 | Q9BQY6 | 478 |
| WFDC10B | FAM181B | A6NEQ2 | 471 |
| WFDC10B | ZNF335 | Q9H4Z2 | 464 |
| WFDC10B | SYS1 | Q8N2H4 | 447 |
| WFDC10B | DNTTIP1 | Q9H147 | 403 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| WFDC10B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| WFDC10B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| WFDC10B | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| WFDC10B | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): KRTAP10-3 (Two-hybrid), UBQLN2 (Two-hybrid)
ESM2 similar proteins: A2A5H7, A4H202, A4H203, A4H204, A4H225, A4H226, A4H227, A4H228, A4H253, A4H254, A4H255, P50704, P50705, P50707, P50708, P50713, P50714, Q30KJ3, Q30KJ7, Q30KK8, Q30KN4, Q30KP9, Q30KT5, Q32P86, Q32ZF7, Q32ZG2, Q32ZG3, Q32ZH2, Q32ZH6, Q3UW41, Q5DQQ6, Q5G865, Q5G866, Q5IAB9, Q5J602, Q6IE40, Q6IE41, Q6IV18, Q7Z7B8, Q8IUB3
Diamond homologs: A2A5H7, Q3UW41, Q6IE41, Q8IUB3, Q8NEX5, Q8NEX6, Q9H1F0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
789 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:45702212:G:GG | donor_gain | 1.0000 |
| 20:45685901:CT:C | donor_gain | 0.9900 |
| 20:45702156:G:GA | donor_gain | 0.9900 |
| 20:45702210:GA:G | donor_gain | 0.9900 |
| 20:45702240:G:T | donor_gain | 0.9900 |
| 20:45703879:G:GT | donor_gain | 0.9900 |
| 20:45704443:GA:G | acceptor_gain | 0.9900 |
| 20:45702155:T:TA | donor_gain | 0.9800 |
| 20:45702188:G:GT | donor_gain | 0.9800 |
| 20:45702240:G:GT | donor_gain | 0.9800 |
| 20:45704443:GAGT:G | acceptor_gain | 0.9800 |
| 20:45685900:A:AC | donor_gain | 0.9700 |
| 20:45685901:C:CC | donor_gain | 0.9700 |
| 20:45704442:A:AG | acceptor_gain | 0.9700 |
| 20:45704443:G:GG | acceptor_gain | 0.9700 |
| 20:45704958:CA:C | donor_gain | 0.9700 |
| 20:45702205:GTTC:G | donor_gain | 0.9600 |
| 20:45702206:TTCT:T | donor_gain | 0.9600 |
| 20:45703930:G:GG | donor_gain | 0.9600 |
| 20:45704590:AACAG:A | donor_loss | 0.9600 |
| 20:45704591:ACAGG:A | donor_loss | 0.9600 |
| 20:45704593:AG:A | donor_loss | 0.9600 |
| 20:45704595:GTA:G | donor_loss | 0.9600 |
| 20:45704596:T:G | donor_loss | 0.9600 |
| 20:45703929:A:AG | donor_gain | 0.9500 |
| 20:45704571:A:T | acceptor_gain | 0.9500 |
| 20:45702208:CTGA:C | donor_loss | 0.9400 |
| 20:45702209:TGAG:T | donor_loss | 0.9400 |
| 20:45702211:AG:A | donor_loss | 0.9400 |
| 20:45702212:GTAG:G | donor_loss | 0.9400 |
AlphaMissense
473 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:45684858:C:G | C65S | 0.915 |
| 20:45684859:A:T | C65S | 0.915 |
| 20:45684846:C:G | C69S | 0.913 |
| 20:45684847:A:T | C69S | 0.913 |
| 20:45684909:C:G | C48S | 0.910 |
| 20:45684910:A:T | C48S | 0.910 |
| 20:45684921:C:G | C44S | 0.907 |
| 20:45684922:A:T | C44S | 0.907 |
| 20:45684855:C:A | G66V | 0.902 |
| 20:45684845:A:C | C69W | 0.900 |
| 20:45684891:C:G | C54S | 0.891 |
| 20:45684892:A:T | C54S | 0.891 |
| 20:45684899:G:C | F51L | 0.889 |
| 20:45684899:G:T | F51L | 0.889 |
| 20:45684901:A:G | F51L | 0.889 |
| 20:45684858:C:T | C65Y | 0.886 |
| 20:45684873:C:G | C60S | 0.878 |
| 20:45684874:A:T | C60S | 0.878 |
| 20:45684908:A:C | C48W | 0.877 |
| 20:45684846:C:T | C69Y | 0.876 |
| 20:45684859:A:G | C65R | 0.876 |
| 20:45684900:A:C | F51C | 0.859 |
| 20:45684860:G:C | F64L | 0.851 |
| 20:45684860:G:T | F64L | 0.851 |
| 20:45684862:A:G | F64L | 0.851 |
| 20:45684892:A:G | C54R | 0.849 |
| 20:45684847:A:G | C69R | 0.847 |
| 20:45684909:C:T | C48Y | 0.845 |
| 20:45684920:G:C | C44W | 0.843 |
| 20:45684870:C:G | C61S | 0.842 |
dbSNP variants (sampled 300 via entrez): RS1000127693 (20:45685887 C>A,G,T), RS1000182242 (20:45693100 C>A,G,T), RS1000324820 (20:45694940 G>A), RS1000336479 (20:45698785 G>A), RS1000418716 (20:45687983 C>T), RS1000508567 (20:45691942 T>G), RS1000685066 (20:45699095 G>A), RS1000818625 (20:45703851 T>G), RS1000864432 (20:45699981 A>C), RS1001056750 (20:45700836 A>C,G), RS1001666548 (20:45693531 G>A,T), RS1001861492 (20:45687182 TG>T), RS1001916107 (20:45688387 C>T), RS1001959132 (20:45685122 A>T), RS1001960808 (20:45692592 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, affects methylation | 2 |
| sotorasib | decreases expression, affects cotreatment | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Folic Acid | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.